Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

Chiu, John H.; Topol, Eric J.; Whitlow, Patrick L.; Hsu, Amy P.; Tuzcu, E.Murat; Franco, Irving; Moliterno, David J.

doi:10.1016/S0002-9149(03)00726-4

« Previous Next »American Journal of Cardiology
Volume 92, Issue 5 , Pages 582-583, 1 September 2003

Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization☆

John H. Chiu, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Eric J. Topol, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Patrick L. Whitlow, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Amy P. Hsu, MS
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
E.Murat Tuzcu, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Irving Franco, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
David J. Moliterno, MD
- Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
- Dr. Moliterno's address is: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, F-25, Cleveland, Ohio 44195, USA.

Received 25 March 2003; received in revised form 21 May 2003; accepted 21 May 2003.

Abstract

The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.